https://www.grail.com | United States | 2016 | $2004.66M
Grail is a US-based biotechnology company known for developing the Galleri multi-cancer early detection blood test. The company aims to reduce cancer mortality through early diagnosis. Despite facing regulatory challenges and controversies, Grail continues to advance its technology and clinical trials to bring innovative cancer detection solutions to the market.
